Long non-coding RNA bladder cancer-associated transcript 2 contributes to disease progression, chemoresistance and poor survival of patients with colorectal cancer

被引:7
作者
Ren, Yongjun [1 ]
Zhao, Caixia [2 ]
He, Yi [3 ]
Xu, Hao [1 ]
Min, Xuli [1 ]
机构
[1] North Sichuan Med Coll, Affiliated Hosp, Sichuan Key Lab Med Imaging, Dept Intervent Radiol, 63 Wenhua Rd, Nanchong 637000, Sichuan, Peoples R China
[2] Nanchong Cent Hosp, Dept Oncol, Nanchong, Sichuan, Peoples R China
[3] North Sichuan Med Coll, Dept Gastrointestinal Surg, Nanchong 637000, Sichuan, Peoples R China
关键词
bladder cancer-associated transcript 2; metastasis; proliferation; drug resistance; prognosis; EXPRESSION;
D O I
10.3892/ol.2019.10487
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colorectal cancer (CRC) is one of the leading causes of cancer-associated mortality worldwide. Long non-coding RNAs (lncRNAs) have been revealed to modulate various biological cell processes, and are involved in the initiation and progression of different diseases, including CRC. However, the role of lncRNA bladder cancer-associated transcript 2 (BLACAT2) in CRC has not been defined. The present study aimed to investigate the role of BLACAT2 in CRC. The present study measured the expression levels of BLACAT2 in CRC cells and tissues by reverse-transcription-quantitative polymerase chain reaction, and associations among BLACAT2 expression levels, important clinicopathological parameters and patient survival were statistically evaluated. The functional role of BLACAT2 in metastasis, proliferation and drug resistance was also detected. BLACAT2 was overexpressed in CRC cells and tissues, and high BLACAT2 expression was associated with larger tumor size, and more advanced lymph node (N), metastasis (M) and tumor-NM stages. Additionally, survival analysis demonstrated that patients with high BLACAT2 expression exhibited poor overall survival. Notably, high BLACAT2 expression was identified as an independent risk factor for overall survival. Migration and invasion assays revealed that BLACAT2 promoted migration and invasion, respectively. In addition, overexpression of BLACAT2 increased colony numbers and optical density values of CRC cells in a colony formation assay and an MTT assay, respectively. Furthermore, BLACAT2 levels were significantly increased in 5-fluorouracil-resistant cells, and overexpression of BLACAT2 was markedly associated with a low cell inhibition rate. In conclusion, BLACAT2 overexpression may contribute to the metastasis, proliferation and chemoresistance of CRC cells, and high BLACAT2 expression may be a promising prognostic marker for patients with CRC.
引用
收藏
页码:2050 / 2058
页数:9
相关论文
共 50 条
  • [41] Up-regulation of long non-coding RNA PCAT-1 correlates with tumor progression and poor prognosis in gastric cancer
    Cui, W-C
    Wu, Y-F
    Qu, H-M
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (13) : 3021 - 3027
  • [42] Long non-coding RNA ZFAS1 correlates with clinical progression and prognosis in cancer patients
    Liu, Fangteng
    Gao, Hui
    Li, Siyu
    Ni, Xiaolin
    Zhu, Zhengming
    ONCOTARGET, 2017, 8 (37) : 61561 - 61569
  • [43] Long non-coding RNA NKILA serves as a biomarker in the early diagnosis and prognosis of patients with colorectal cancer
    Jiang, Peng
    Han, Xiaoting
    Zheng, Yingnan
    Sui, Jianchao
    Bi, Weiping
    ONCOLOGY LETTERS, 2019, 18 (02) : 2109 - 2117
  • [44] Long non-coding RNA AC087388.1 as a novel biomarker in colorectal cancer
    Poursheikhani, Arash
    Abbaszadegan, Mohammad Reza
    Kerachian, Mohammad Amin
    BMC CANCER, 2022, 22 (01)
  • [45] Long non-coding RNA HIT000218960 is associated with poor prognosis in patients with gastric cancer
    Dong, Kunbo
    Bai, Li
    Tong, Deyong
    Shi, Xiuna
    Wei, Sirong
    Cai, Yongguo
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (01)
  • [46] Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients
    Peng, LingLong
    Wang, Rong
    Shang, JingKun
    Xiong, YongFu
    Fu, ZhongXue
    ONCOTARGET, 2017, 8 (09) : 15057 - 15070
  • [47] Long non-coding RNA HOXA transcript at the distal tip as a biomarker for gastric cancer
    Yang, Yuchong
    Ma, Bin
    Yan, Ying
    Song, Yongxi
    Gao, Peng
    Sun, Jingxu
    Wang, Jiajun
    Wang, Zhenning
    ONCOLOGY LETTERS, 2017, 14 (01) : 1068 - 1072
  • [48] Long non-coding RNA HNFIA-ASI up-regulation in non-small cell lung cancer correlates to poor survival
    Ma, Y. -F.
    Liang, T.
    Li, C. -R.
    Li, Y. -J.
    Jin, S.
    Liu, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (23) : 4858 - 4863
  • [49] Dysregulation of long non-coding RNA profiles in human colorectal cancer and its association with overall survival
    Yang, Lei
    Xu, Lingling
    Wang, Qian
    Wang, Min
    An, Guangyu
    ONCOLOGY LETTERS, 2016, 12 (05) : 4068 - 4074
  • [50] Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients
    Xu, Chen
    Cui, Hongli
    Li, Huazhi
    Wu, Yongzhe
    An, Hongchao
    Guo, Chunhai
    JOURNAL OF BUON, 2019, 24 (02): : 663 - 671